Allianz Asset Management GmbH Grows Stock Holdings in Globe Life Inc. $GL

Allianz Asset Management GmbH grew its holdings in Globe Life Inc. (NYSE:GL) by 1,259.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 53,007 shares of the company’s stock after acquiring an additional 49,107 shares during the period. Allianz Asset Management GmbH’s holdings in Globe Life were worth $6,588,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Dimensional Fund Advisors LP boosted its holdings in shares of Globe Life by 9.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,741,131 shares of the company’s stock valued at $229,323,000 after acquiring an additional 148,397 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its holdings in shares of Globe Life by 35.9% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,025,984 shares of the company’s stock valued at $135,143,000 after acquiring an additional 271,253 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Globe Life in the 1st quarter valued at $131,608,000. Pzena Investment Management LLC boosted its holdings in Globe Life by 0.5% during the second quarter. Pzena Investment Management LLC now owns 945,983 shares of the company’s stock worth $117,576,000 after buying an additional 5,103 shares in the last quarter. Finally, Swedbank AB boosted its holdings in Globe Life by 77.0% during the first quarter. Swedbank AB now owns 832,000 shares of the company’s stock worth $109,591,000 after buying an additional 362,000 shares in the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Stock Performance

GL opened at $135.52 on Thursday. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. The company has a market cap of $10.98 billion, a price-to-earnings ratio of 10.83 and a beta of 0.55. Globe Life Inc. has a 52-week low of $100.27 and a 52-week high of $147.83. The firm’s fifty day simple moving average is $139.63 and its two-hundred day simple moving average is $129.18.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.54 by $0.27. The business had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.52 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. During the same period last year, the firm posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Equities analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life’s dividend payout ratio (DPR) is presently 8.63%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on GL shares. JPMorgan Chase & Co. increased their price target on shares of Globe Life from $145.00 to $160.00 and gave the stock an “overweight” rating in a report on Tuesday, July 8th. Keefe, Bruyette & Woods increased their price target on shares of Globe Life from $145.00 to $155.00 and gave the stock an “outperform” rating in a report on Monday, July 28th. BMO Capital Markets reissued a “market perform” rating and set a $149.00 price target (up from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Truist Financial started coverage on shares of Globe Life in a report on Tuesday, July 15th. They set a “buy” rating and a $150.00 price target on the stock. Finally, Wells Fargo & Company increased their price target on shares of Globe Life from $150.00 to $172.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Eight equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and a consensus price target of $152.11.

Insider Activity at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 28,952 shares of the stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total transaction of $4,081,363.44. Following the transaction, the chief financial officer directly owned 30,665 shares of the company’s stock, valued at $4,322,845.05. This trade represents a 48.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO James Matthew Darden sold 33,270 shares of the firm’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $135.59, for a total transaction of $4,511,079.30. Following the completion of the transaction, the chief executive officer directly owned 49,842 shares in the company, valued at approximately $6,758,076.78. This represents a 40.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 84,722 shares of company stock valued at $11,733,793. 1.51% of the stock is currently owned by company insiders.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.